It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Oxidative stress contributes to the pathogenesis of acute lung injury. Protein S-glutathionylation plays an important role in cellular antioxidant defense. Here we report that the expression of deglutathionylation enzyme Grx1 is decreased in the lungs of acute lung injury mice. The acute lung injury induced by hyperoxia or LPS is significantly relieved in Grx1 KO and Grx1fl/flLysMcre mice, confirming the protective role of Grx1-regulated S-glutathionylation in macrophages. Using a quantitative redox proteomics approach, we show that FABP5 is susceptible to S-glutathionylation under oxidative conditions. S-glutathionylation of Cys127 in FABP5 promotes its fatty acid binding ability and nuclear translocation. Further results indicate S-glutathionylation promotes the interaction of FABP5 and PPARβ/δ, activates PPARβ/δ target genes and suppresses the LPS-induced inflammation in macrophages. Our study reveals a molecular mechanism through which FABP5 S-glutathionylation regulates macrophage inflammation in the pathogenesis of acute lung injury.
Redox-dependent regulation plays a key role in the pathogenesis of acute lung injury, but its mechanism is unclear. Here the authors show Grx1-regulated S-glutathionylation of FABP5 controls macrophage inflammation and alleviates acute lung injury.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Cheng Hongqiang 5
; Ke Yuehai 6
; Zhang, Xue 7
1 Zhejiang University School of Medicine, Department of Pathology and Pathophysiology and Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University School of Medicine, Institute of Immunology, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
2 Zhejiang University School of Medicine, Department of Pathology and Pathophysiology and Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
3 Zhejiang University School of Medicine, Department of Biochemistry, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
4 Zhejiang University School of Medicine, Institute of Immunology, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
5 Zhejiang University School of Medicine, Department of Pathology and Pathophysiology and Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University School of Medicine, Department of Cardiology of Second Affiliated Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
6 Zhejiang University School of Medicine, Department of Pathology and Pathophysiology and Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University School of Medicine, Department of Respiratory Medicine of Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University Medical Center, Zhejiang Laboratory for Systems and Precision Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
7 Zhejiang University School of Medicine, Department of Pathology and Pathophysiology and Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University School of Medicine, Department of Respiratory Medicine of Sir Run Run Shaw Hospital, Hangzhou, P.R. China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)




